QualityStocks would like to highlight HST Global, Inc. (OTCBB: HSTC). The company is a development stage biotechnology company that acquires and develops innovative products for the treatment of cancer and other life threatening illnesses. HST focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, then developing those drug candidates for commercial use and developing a network of Wellness Centers Worldwide.
In the company’s recent news,
HST Global, Inc. announced that Dr. Kyl Smith has joined its Scientific Board. Much of Dr. Smith’s visibility has been earned in the world of natural medicine. He is a noted researcher, inventor, lecturer, author and scientist, and is known as the inventor of Focus Factor®, the number-one selling brain support product in North America for the last seven years.
Dr. Kyl’s passion is teaching doctors how to use nutritional therapies to improve cognitive function. He has been featured on numerous radio and television programs across the country, is the author of the acclaimed Brighter Mind® book series and is a popular speaker providing Continuing Education programs for physicians.
With the help of a team of top scientists, Dr. Kyl filed a Health Claim Petition for Phosphatidylserine, which was approved by the Food and Drug Administration (FDA) in 2002. This unprecedented achievement represents the first Health Claim for cognitive function to be approved in the FDA’s history.
Ronald Howell, President and CEO of HST Global, Inc. stated, “There is a growing acceptance of integrative wellness and cancer treatments worldwide and HST is perfectly positioned to open our own brand of Integrative Wellness and Cancer Treatment Centers.”
Commenting on the announcement, Mr. Howell continued, “The addition of Dr. Kyl Smith to our Scientific Advisory Board will enable the company to strengthen our ability to address multiple challenges individuals face in the maintenance and treatment of numerous health conditions, and to provide Continuing Education modules and courses for physicians who wish to learn about scientifically validated integrative therapies.”
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
